Unveiling Lotus DermaBotanics: A Revolution in Skincare!

In today’s fast-paced world, skincare has become an essential part of daily life. As our primary defence against environmental aggressors, our skin is constantly exposed to harmful rays and pollutants, making its protection and care more critical than ever. These harsh conditions can lead to various skin issues, including hyperpigmentation, redness, and a weakened skin barrier. Understanding these challenges, Lotus DermaBotanics, a revolutionary dermaceutical skincare range, is meticulously designed to deliver both immediate and long-lasting results, making it a unique and essential addition to any skincare routine.

Lotus DermaBotanics stands out for its holistic approach to skincare, combining potent ingredients like kojic acid and multi-berry complexes with natural botanical extracts. Each product in the DermaBotanics range is rigorously tested and dermatologist-approved, ensuring they maintain the skin’s natural pH balance of 5.5 and are paraben-free. DermaBotanics is currently available in two innovative targeted ranges: Kojic Acid + Multi Berries, designed to address melasma, dark spots, and pigmentation, and Peptide + Papaya, which focuses on providing firmer, more youthful skin. This blend ensures comprehensive care that addresses multiple skin concerns, including deep hydration, skin brightening, and anti-aging benefits. 

“We are thrilled to introduce Lotus DermaBotanics, a first-of-its-kind concept. This advanced skincare range is the result of 30 years of dedicated research and development. This unique combination of potent actives and avant-garde natural extracts makes DermaBotanics effective, safe, and suitable for all skin types,” says Mr. Nitin Passi, Chairman and Managing Director of Lotus Herbals.

The key products include, the Lotus DermaBotanics Deep Hydra Crème which is a premium moisturizer formulated for normal to combination skin types, offering intense hydration with a rich, non-greasy texture. Infused with peptides, and papaya extract, it nourishes the skin, strengthens the skin barrier, and reduces fine lines. It protects against environmental stressors, calms irritation and redness, and enhances skin elasticity and firmness. Designed for daily use, it replenishes, rejuvenates, and brightens the skin, promoting a youthful glow.

The Kojic Acid and Multi Berry Serum features a powerful blend of kojic acid and berry extracts from strawberries, raspberries, blueberries, cranberries, and acai berries. It targets hyperpigmentation and dark spots while providing antioxidant protection. Its lightweight, easily absorbable formula penetrates deep into the skin’s layers. The serum boosts collagen production, hydrates, calms inflammation, and improves skin firmness, offering a comprehensive solution for vibrant, healthy skin.

The brand continues to set new benchmarks in the skincare industry with the launch of Lotus DermaBotanics. By combining the best of nature and science, results have proven that this innovative range delivers long-term benefits, ensuring healthy, beautiful skin for all. Experience the future of skincare with Lotus DermaBotanics and embrace the journey to a radiant complexion.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More